<DOC>
	<DOCNO>NCT01510405</DOCNO>
	<brief_summary>The investigator characterize preclinical Non-Small Cell Lung Cancer ( NSCLC ) model proteomic expression profile associate exposure Aurora Polo-like kinase inhibitor . The identification proteomic expression pattern patient NSCLC would important step define possible role agent potential targeted therapy clinically important disease . This study propose evaluate resect non-small cell lung cancer specimens proteomic expression profile .</brief_summary>
	<brief_title>Phosphoproteomic Patterns Novel Biomarker Aurora Polo-like Kinase Inhibitors Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Subjects undergo undergone thoracic surgery presume lung cancer Wedge resection , lobectomy , bilobectomy , segmentectomy pneumonectomy thoracic surgical operation permit . Age â‰¥ 18 year . Subject meet criteria thoracic surgery determine thoracic surgeon . Able provide write informed consent . Subjects undergo undergone thoracic surgery metastatic disease primary source colorectal cancer , sarcoma , melanoma , breast cancer , bladder cancer , prostate cancer , esophageal cancer , pancreatic cancer , gastric cancer exclude . Subjects receive prior preoperative lung cancer anticancer therapy exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Subjects undergo undergone thoracic surgery presume lung cancer .</keyword>
	<keyword>The following procedure allow : Wedge resection , lobectomy , bilobectomy , segmentectomy pneumonectomy thoracic surgical operation permit .</keyword>
</DOC>